Recombinant Human KCNK13 Protein，His

KCNK13, also known as TASK-3, is a member of the two-pore domain potassium channel family that plays a crucial role in regulating neuronal excitability and maintaining potassium ion homeostasis. The channel is expressed in various tissues, including the brain, heart, and kidney, and its activity is modulated by several factors such as pH, lipids, and specific pharmacological agents. The investigation of KCNK13 recombinant protein has garnered significant attention due to its potential implications in various physiological and pathological processes, including pain signaling, mood disorders, and respiratory control. Studies have demonstrated that KCNK13 is involved in the modulation of synaptic activity and neuronal firing, making it a potential target for therapeutic interventions. Additionally, mutations or dysregulation of KCNK13 have been linked to cardiac arrhythmias and other disorders, underscoring the need for a deeper understanding of its functional mechanisms. By producing recombinant KCNK13, researchers can explore its structural and functional properties, screen for specific inhibitors or activators, and investigate its role in disease models. This research not only enhances our knowledge of potassium channels but also provides insights into the broader context of ion channel pharmacology and potential drug development strategies aimed at treating conditions related to KCNK13 dysregulation. Understanding KCNK13's mechanisms and interactions could pave the way for novel therapeutic approaches that target ion channelopathies and improve patient outcomes.